84712-92-5 Usage
Description
(5alpha,7alpha)-alpha-tert-butyl-17-(cyclopropylcarbonyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol is a complex organic molecule with a morphinan core structure. It contains a hydroxyl group, a methoxy group, and a cyclopropylcarbonyl group, as well as a tert-butyl and a methyl group. It also features a cyclic ether ring and a double bond. (5alpha,7alpha)-alpha-tert-butyl-17-(cyclopropylcarbonyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol is likely to have pharmacological properties and may be used in medicinal chemistry research or drug development. It could potentially have effects on the central nervous system, given its structural similarity to other psychoactive compounds.
Uses
Used in Pharmaceutical Industry:
(5alpha,7alpha)-alpha-tert-butyl-17-(cyclopropylcarbonyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol is used as a potential therapeutic agent for its possible effects on the central nervous system, due to its structural similarity to other psychoactive compounds.
Used in Medicinal Chemistry Research:
(5alpha,7alpha)-alpha-tert-butyl-17-(cyclopropylcarbonyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol is used as a subject of study for understanding its pharmacological properties and potential applications in drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 84712-92-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,7,1 and 2 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 84712-92:
(7*8)+(6*4)+(5*7)+(4*1)+(3*2)+(2*9)+(1*2)=145
145 % 10 = 5
So 84712-92-5 is a valid CAS Registry Number.
84712-92-5Relevant articles and documents
DEUTERATED COMPOUND AND MEDICAL USE THEREOF
-
, (2020/01/12)
The present invention relates to a compound represented by formula I and a non-toxic pharmaceutically acceptable salt thereof. In formula (I), R1 is H, CH3 or deuterated methyl (CD3); R2 is CH3 or CH2CH3; R3, R4 and R5 are each independently H or deuterium (D); when R1 is H or CH3, at least one of R3, R4 and R5 is D.
